• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫代磷酸寡核苷酸与 RNase H1 的结合会导致蛋白质构象发生变化,并改变 RNase H1 与其他蛋白质的相互作用。

Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins.

机构信息

Core Antisense Research, Ionis Pharmaceuticals, Inc., 2855 Gazelle Court, Carlsbad, CA 92010, USA.

Antisense Drug discovery, Ionis Pharmaceuticals, Inc. Carlsbad, CA 92010, USA.

出版信息

Nucleic Acids Res. 2021 Mar 18;49(5):2721-2739. doi: 10.1093/nar/gkab078.

DOI:10.1093/nar/gkab078
PMID:33577678
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7969025/
Abstract

We recently found that toxic PS-ASOs can cause P54nrb and PSF nucleolar mislocalization in an RNase H1-dependent manner. To better understand the underlying mechanisms of these observations, here we utilize different biochemical approaches to demonstrate that PS-ASO binding can alter the conformations of the bound proteins, as illustrated using recombinant RNase H1, P54nrb, PSF proteins and various isolated domains. While, in general, binding of PS-ASOs or ASO/RNA duplexes stabilizes the conformations of these proteins, PS-ASO binding may also cause the unfolding of RNase H1, including both the hybrid binding domain and the catalytic domain. The extent of conformational change correlates with the binding affinity of PS-ASOs to the proteins. Consequently, PS-ASO binding to RNase H1 induces the interaction of RNase H1 with P54nrb or PSF in a 2'-modification and sequence dependent manner, and toxic PS-ASOs tend to induce more interactions than non-toxic PS-ASOs. PS-ASO binding also enhances the interaction between P54nrb and PSF. However, the interaction between RNase H1 and P32 protein can be disrupted upon binding of PS-ASOs. Together, these results suggest that stronger binding of PS-ASOs can cause greater conformational changes of the bound proteins, subsequently affecting protein-protein interactions. These observations thus provide deeper understanding of the molecular basis of PS-ASO-induced protein mislocalization or degradation observed in cells and advance our understanding of why some PS-ASOs are cytotoxic.

摘要

我们最近发现,毒性 PS-ASO 可以以依赖于 RNase H1 的方式导致 P54nrb 和 PSF 核仁定位错误。为了更好地理解这些观察结果的潜在机制,我们在这里利用不同的生化方法证明 PS-ASO 结合可以改变结合蛋白的构象,如图所示,使用重组 RNase H1、P54nrb、PSF 蛋白和各种分离的结构域。虽然 PS-ASO 或 ASO/RNA 双链体的结合通常会稳定这些蛋白质的构象,但 PS-ASO 结合也可能导致 RNase H1 的展开,包括杂交结合域和催化域。构象变化的程度与 PS-ASO 与蛋白质的结合亲和力相关。因此,PS-ASO 与 RNase H1 的结合以 2'-修饰和序列依赖性方式诱导 RNase H1 与 P54nrb 或 PSF 的相互作用,并且毒性 PS-ASO 倾向于诱导比非毒性 PS-ASO 更多的相互作用。PS-ASO 结合还增强了 P54nrb 和 PSF 之间的相互作用。然而,PS-ASO 结合会破坏 RNase H1 和 P32 蛋白之间的相互作用。总之,这些结果表明,PS-ASO 更强的结合可以导致结合蛋白发生更大的构象变化,从而影响蛋白质-蛋白质相互作用。这些观察结果因此提供了对细胞中观察到的 PS-ASO 诱导的蛋白质定位错误或降解的分子基础的更深入理解,并增进了我们对为什么一些 PS-ASO 具有细胞毒性的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/29184c52ea38/gkab078fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/deed5972bd4c/gkab078fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/3f0320beefea/gkab078fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/0370d7d7ce11/gkab078fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/13bd3980681a/gkab078fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/e600079d9235/gkab078fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/aa92460324f9/gkab078fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/9db0be725874/gkab078fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/6cf3ff7bedab/gkab078fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/29184c52ea38/gkab078fig9.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/deed5972bd4c/gkab078fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/3f0320beefea/gkab078fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/0370d7d7ce11/gkab078fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/13bd3980681a/gkab078fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/e600079d9235/gkab078fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/aa92460324f9/gkab078fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/9db0be725874/gkab078fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/6cf3ff7bedab/gkab078fig8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2bfd/7969025/29184c52ea38/gkab078fig9.jpg

相似文献

1
Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins.硫代磷酸寡核苷酸与 RNase H1 的结合会导致蛋白质构象发生变化,并改变 RNase H1 与其他蛋白质的相互作用。
Nucleic Acids Res. 2021 Mar 18;49(5):2721-2739. doi: 10.1093/nar/gkab078.
2
Kinetic and subcellular analysis of PS-ASO/protein interactions with P54nrb and RNase H1.与 P54nrb 和 RNase H1 的 PS-ASO/蛋白质相互作用的动力学和亚细胞分析。
Nucleic Acids Res. 2019 Nov 18;47(20):10865-10880. doi: 10.1093/nar/gkz771.
3
Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2'-modifications and enhances antisense activity.热休克蛋白90(Hsp90)与含有疏水性2'-修饰的硫代磷酸酯寡核苷酸相互作用,并增强反义活性。
Nucleic Acids Res. 2016 May 5;44(8):3892-907. doi: 10.1093/nar/gkw144. Epub 2016 Mar 3.
4
NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate Oligonucleotides.NAT10 和 DDX21 蛋白与 RNase H1 相互作用并影响硫代磷酸寡核苷酸的性能。
Nucleic Acid Ther. 2022 Aug;32(4):280-299. doi: 10.1089/nat.2021.0107. Epub 2022 Jul 18.
5
Understanding the effect of controlling phosphorothioate chirality in the DNA gap on the potency and safety of gapmer antisense oligonucleotides.了解控制 DNA 间隙中硫代磷酸酯手性对 gapmer 反义寡核苷酸效力和安全性的影响。
Nucleic Acids Res. 2020 Feb 28;48(4):1691-1700. doi: 10.1093/nar/gkaa031.
6
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.对 PS-ASO 治疗药物进行化学修饰可降低细胞内蛋白质结合,提高治疗指数。
Nat Biotechnol. 2019 Jun;37(6):640-650. doi: 10.1038/s41587-019-0106-2. Epub 2019 Apr 29.
7
Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins.通过调节与细胞蛋白的相互作用,使硫代磷酸酯与烷基膦酸酯键在特定部位进行替换,增强了 gapmer ASO 的治疗谱。
Nucleic Acids Res. 2019 Jun 20;47(11):5465-5479. doi: 10.1093/nar/gkz247.
8
Intra-endosomal trafficking mediated by lysobisphosphatidic acid contributes to intracellular release of phosphorothioate-modified antisense oligonucleotides.由溶血双磷脂酸介导的内体运输有助于硫代磷酸酯修饰的反义寡核苷酸的细胞内释放。
Nucleic Acids Res. 2017 May 19;45(9):5309-5322. doi: 10.1093/nar/gkx231.
9
Acute hepatotoxicity of 2' fluoro-modified 5-10-5 gapmer phosphorothioate oligonucleotides in mice correlates with intracellular protein binding and the loss of DBHS proteins.氟代修饰 5-10-5 间隙寡核苷酸硫代磷酸酯在小鼠中的急性肝毒性与细胞内蛋白结合和 DBHS 蛋白丢失相关。
Nucleic Acids Res. 2018 Mar 16;46(5):2204-2217. doi: 10.1093/nar/gky060.
10
RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.RNase H1 依赖性反义寡核苷酸在细胞质和细胞核中均能有效地指导 RNA 切割。
Mol Ther. 2017 Sep 6;25(9):2075-2092. doi: 10.1016/j.ymthe.2017.06.002. Epub 2017 Jun 27.

引用本文的文献

1
Chemical Modifications in Nucleic Acid Therapeutics.核酸疗法中的化学修饰
Methods Mol Biol. 2025;2965:57-126. doi: 10.1007/978-1-0716-4742-4_3.
2
Scalable modulation of CRISPR‒Cas enzyme activity using photocleavable phosphorothioate DNA.使用光可裂解硫代磷酸酯DNA对CRISPR-Cas酶活性进行可扩展调节。
Nat Commun. 2025 Jul 1;16(1):5939. doi: 10.1038/s41467-025-61094-5.
3
Metabolic Stability and Targeted Delivery of Oligonucleotides: Advancing RNA Therapeutics Beyond The Liver.寡核苷酸的代谢稳定性与靶向递送:推动RNA疗法超越肝脏应用。

本文引用的文献

1
The Interaction of Phosphorothioate-Containing RNA Targeted Drugs with Proteins Is a Critical Determinant of the Therapeutic Effects of These Agents.含硫代磷酸酯的 RNA 靶向药物与蛋白质的相互作用是这些药物治疗效果的关键决定因素。
J Am Chem Soc. 2020 Sep 2;142(35):14754-14771. doi: 10.1021/jacs.0c04928. Epub 2020 Aug 18.
2
Phosphorothioate modified oligonucleotide-protein interactions.硫代磷酸酯修饰的寡核苷酸-蛋白质相互作用。
Nucleic Acids Res. 2020 Jun 4;48(10):5235-5253. doi: 10.1093/nar/gkaa299.
3
Kinetic and subcellular analysis of PS-ASO/protein interactions with P54nrb and RNase H1.
J Med Chem. 2025 Apr 10;68(7):6870-6896. doi: 10.1021/acs.jmedchem.4c02528. Epub 2025 Jan 8.
4
Development of bioconjugate-based delivery systems for nucleic acids.基于生物共轭物的核酸递送系统的开发。
RNA. 2024 Dec 16;31(1):1-13. doi: 10.1261/rna.080273.124.
5
The Combination of Mesyl-Phosphoramidate Inter-Nucleotide Linkages and 2'--Methyl in Selected Positions in the Antisense Oligonucleotide Enhances the Performance of RNaseH1 Active PS-ASOs.在反义寡核苷酸中,在选定位置引入亚甲基膦酸酯核苷间键和 2'-甲基修饰可以增强 RNaseH1 活性 PS-ASO 的性能。
Nucleic Acid Ther. 2022 Oct;32(5):401-411. doi: 10.1089/nat.2022.0005. Epub 2022 Jul 20.
6
NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate Oligonucleotides.NAT10 和 DDX21 蛋白与 RNase H1 相互作用并影响硫代磷酸寡核苷酸的性能。
Nucleic Acid Ther. 2022 Aug;32(4):280-299. doi: 10.1089/nat.2021.0107. Epub 2022 Jul 18.
7
Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides.鉴定降低 Gapmer 反义寡核苷酸肝毒性的碱基化学修饰。
Nucleic Acids Res. 2022 Jul 22;50(13):7224-7234. doi: 10.1093/nar/gkac562.
8
RNA modifications can affect RNase H1-mediated PS-ASO activity.RNA修饰可影响核糖核酸酶H1介导的PS-ASO活性。
Mol Ther Nucleic Acids. 2022 May 11;28:814-828. doi: 10.1016/j.omtn.2022.05.024. eCollection 2022 Jun 14.
9
Structural basis of dimerization and nucleic acid binding of human DBHS proteins NONO and PSPC1.人 NONO 和 PSPC1 蛋白二聚化和核酸结合的结构基础。
Nucleic Acids Res. 2022 Jan 11;50(1):522-535. doi: 10.1093/nar/gkab1216.
10
Nanoparticles-Based Oligonucleotides Delivery in Cancer: Role of Zebrafish as Animal Model.基于纳米颗粒的寡核苷酸在癌症中的递送:斑马鱼作为动物模型的作用
Pharmaceutics. 2021 Jul 21;13(8):1106. doi: 10.3390/pharmaceutics13081106.
与 P54nrb 和 RNase H1 的 PS-ASO/蛋白质相互作用的动力学和亚细胞分析。
Nucleic Acids Res. 2019 Nov 18;47(20):10865-10880. doi: 10.1093/nar/gkz771.
4
RNases H: Structure and mechanism.核糖核酸酶 H:结构与机制。
DNA Repair (Amst). 2019 Dec;84:102672. doi: 10.1016/j.dnarep.2019.102672. Epub 2019 Jul 20.
5
Antisense Oligonucleotide Therapies for Neurodegenerative Diseases.反义寡核苷酸疗法治疗神经退行性疾病。
Annu Rev Neurosci. 2019 Jul 8;42:385-406. doi: 10.1146/annurev-neuro-070918-050501.
6
Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index.对 PS-ASO 治疗药物进行化学修饰可降低细胞内蛋白质结合,提高治疗指数。
Nat Biotechnol. 2019 Jun;37(6):640-650. doi: 10.1038/s41587-019-0106-2. Epub 2019 Apr 29.
7
Site-specific replacement of phosphorothioate with alkyl phosphonate linkages enhances the therapeutic profile of gapmer ASOs by modulating interactions with cellular proteins.通过调节与细胞蛋白的相互作用,使硫代磷酸酯与烷基膦酸酯键在特定部位进行替换,增强了 gapmer ASO 的治疗谱。
Nucleic Acids Res. 2019 Jun 20;47(11):5465-5479. doi: 10.1093/nar/gkz247.
8
RNA-Targeted Therapeutics.RNA 靶向治疗药物。
Cell Metab. 2018 Apr 3;27(4):714-739. doi: 10.1016/j.cmet.2018.03.004.
9
Dynamic nucleoplasmic and nucleolar localization of mammalian RNase H1 in response to RNAP I transcriptional R-loops.哺乳动物核糖核酸酶H1响应核糖核酸聚合酶I转录R环时的动态核质和核仁定位
Nucleic Acids Res. 2017 Oct 13;45(18):10672-10692. doi: 10.1093/nar/gkx710.
10
RNase H1-Dependent Antisense Oligonucleotides Are Robustly Active in Directing RNA Cleavage in Both the Cytoplasm and the Nucleus.RNase H1 依赖性反义寡核苷酸在细胞质和细胞核中均能有效地指导 RNA 切割。
Mol Ther. 2017 Sep 6;25(9):2075-2092. doi: 10.1016/j.ymthe.2017.06.002. Epub 2017 Jun 27.